Ligand validation:4JM5

MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4JM5_MES_A_303	97%	13%	0.065	0.983	1.2	2.87	1	7	1	0	100%	0.4
4XV6_MES_A_302	98%	47%	0.063	0.988	0.87	1.2	1	3	0	0	100%	1
4NVF_MES_A_301	98%	14%	0.062	0.986	2.14	1.92	1	3	0	0	100%	1
4JQN_MES_A_303	83%	18%	0.103	0.961	1.77	1.92	2	3	4	0	100%	0.3
5U5V_MES_A_303	83%	20%	0.107	0.965	2.03	1.52	1	2	0	0	100%	0.26
4NVJ_MES_B_303	74%	43%	0.115	0.947	0.87	1.38	1	2	0	0	100%	0.35
8AJQ_MES_H_201	100%	39%	0.037	0.992	1.52	0.93	1	1	0	0	100%	1
4NWT_MES_L_301	100%	25%	0.045	0.99	1.24	1.94	2	4	0	0	100%	1
4S23_MES_B_502	100%	24%	0.05	0.993	1.97	1.34	1	1	0	0	100%	1
5NJ9_MES_A_502	99%	61%	0.049	0.988	0.71	0.74	-	1	0	0	100%	1
4BRG_MES_B_1399	99%	13%	0.061	0.988	1.72	2.42	3	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.